ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000689.1|2-deoxystreptamine_1 # 3 # 86 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.619	BGC0000689.1|2-deoxystreptamine_1 	3	86	-	Loose	2000	20.4014	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	57.14	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGGTTTCCCGGGCGAACCTTCGGGATAATCCGGTGGCTGCGGTTGCCCAGGGAAACCTAATTCTGACTGAACAGCCGGTACGG	MVSRANLRDNPVAAVAQGNLILTEQPVR	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	2.36	gnl|BL_ORD_ID|4719|hsp_num:0	2914			1887	1929	rifampin
BGC0000689.1|2-deoxystreptamine_2 # 218 # 424 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.647	BGC0000689.1|2-deoxystreptamine_2 	218	424	-	Loose	400	23.0978	salD	53.33	3007028	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGTCCTGGCTACCTTCTCTCGCCGATTTGACCCTTGCCCAGGAGTGCCACCGGGATCGGCGCCGGGCTGTCCGGCCGGCGCGCCAGCTGGGCTCGCTCGACCTGTGGTCGGCGACTGCCATCAGCTATCCCCAAGGGACACCGTGGCCGCCAGCATATAGCACTGTAACTATGCGCGGAATGGCCGAAACAGCTACTGACGTTTAG	MSWLPSLADLTLAQECHRDRRRAVRPARQLGSLDLWSATAISYPQGTPWPPAYSTVTMRGMAETATDV	MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN	12.50	gnl|BL_ORD_ID|4727|hsp_num:0	5739			225	270	lincomycin; virginiamycin M1; tiamulin; retapamulin
BGC0000689.1|2-deoxystreptamine_3 # 438 # 1775 # 1 # ID=1_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	BGC0000689.1|2-deoxystreptamine_3 	438	1775	+	Loose	200	28.4906	vanH gene in vanB cluster	24.43	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	TTGACGAACCGGGGGCTGGTCGAGCGGGCCCGTCGGGTGACCGCAGCGGAGAACTACGACATCGGGACCCGCTTCTCGGCGATGATCCAGTCGGGCGAGGGCGCGTGGCTGACCGACGTCGAGGGCAACCGTTACGTCGACCTCACCGCCTCCAGCGGGACGATCATCCTCGGTCACCGGAATCAGGCGGTGACCGAGGCGATCACGCGGCAGATTCGGGATTTCGGTACGGCGTTCGCGTCGACGTTGTCGGTTCCGCGGGTGGAGTTGGCGGAGCGGTTGTGTGAGCGGTACGAGTGTGCGGAGAAGGTGGTCTTCCACAAGACCGGCTCCGAGGGTACGGCGATGGCGGCTCGTCTGGCGCGGGCGGCGACCGGTCGTGAGTTGATCCTGTCGTGTGGATATCACGGCTGGCACGAGTGGCAGTTGGCGGGCGAGACGTTCGGGTACCAGCAGACCACCGGTGTGGTCGGTTTCGGGTACAACGAGAAGGCCCTGGCGAAGATGCTGGAGGCCTTCGGTAACGAGGTGGCCGGGGTGCTGATCTCGCCGGAGCTGCTGTACTTCGATGTCGAGTTCTACCAGCGCATGTATGCGTTGTGTGCGCGGTATGACGTGCCGTTCATGATGGACGAGGTGTACACCGGGTTCCGGGCGGGGCCGAAGGGTGTGCACGGGTTGGGTGTGCCGGCTGACGTGGTGGTGGTCAGCAAGGGTCTGGCGAATGGTCATTCGTTGGCGGCGGTGATGGGTCGTCGGGACATCATCGATGCGTATGACGTGTCGGGGATCCAGGGGACGTACACGCGGGAGGTGCCGCCGATGGCGGCGGCGATGGCGGTGTTGGATGTGCTGGACACGCCGGGTGTGTACGAGCACGCGGAGGCGATGGGCCGTCGGCTGGCGGACGGTATGCGGGAGATCCTCACCGGTGAGGGGATTCCGAACTGGGTGGGTGGCCCGGCCCTGATGTTCGATACGGTGCTGCCGAATGACGATCTGGGTTGGGAGATCTACAAGACGGCGCACGACTTCGGGGTGTACTTCGAGGATTCCGGGACGCAGTTGGTGACGACGGCGTTCGACGAGGCGGCGGTGGACCACGCGTTGACGGCGTTCCGTAAGGCGACGCGTCAGGTGATCGCGGATCGGCCGGACATCGCGCCGACGTCGGGTGGTGAGTTGACGGAGGAGCGGAAGCTGGACTTCGCGGAGGAGGCCTTCGGTGGTCTGCTGCGTGACGACGAGCGGACGAACGCGTTGATCGACGAGACCATCGAGAAGGTGGTCAACCGGGACCGCAGCATCAAGCCGGTTCTCATCCCCGCCCAGAACTGA	MTNRGLVERARRVTAAENYDIGTRFSAMIQSGEGAWLTDVEGNRYVDLTASSGTIILGHRNQAVTEAITRQIRDFGTAFASTLSVPRVELAERLCERYECAEKVVFHKTGSEGTAMAARLARAATGRELILSCGYHGWHEWQLAGETFGYQQTTGVVGFGYNEKALAKMLEAFGNEVAGVLISPELLYFDVEFYQRMYALCARYDVPFMMDEVYTGFRAGPKGVHGLGVPADVVVVSKGLANGHSLAAVMGRRDIIDAYDVSGIQGTYTREVPPMAAAMAVLDVLDTPGVYEHAEAMGRRLADGMREILTGEGIPNWVGGPALMFDTVLPNDDLGWEIYKTAHDFGVYFEDSGTQLVTTAFDEAAVDHALTAFRKATRQVIADRPDIAPTSGGELTEERKLDFAEEAFGGLLRDDERTNALIDETIEKVVNRDRSIKPVLIPAQN	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	137.77	gnl|BL_ORD_ID|4673|hsp_num:0	626			132	519	vancomycin
BGC0000689.1|2-deoxystreptamine_4 # 1813 # 2625 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000689.1|2-deoxystreptamine_4 	1813	2625	+	Loose	500	182.185	APH(3')-Vc	44.24	3002651	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGGTTGCAGCACCGATACCGGTGGCTGGCTGGGGCGACAAGGACGACCCGTGGGAGTGCCTGGGCGAGCGTTCGTCCGGCGCGACGGTCTACCGCGTGGGGGAGGTTCCCTCCTTCTACGTGAAGACCACGCCGCCCAGGCACCCTGACGACCACCGGTTCAACCCGACCAAGGAGGCCGAGCGGCTCCGCTGGCTGGCCGCCCAGGGGCTGCCCGTCCCCGAGGTGGTGGCCCTCGATGCCAACGACGAGCTGGCGTGGGTGGTCACCAGGGCGCTGCCCGGGCGGCCCGCCGCCCGGCACTGGAAACCGGAGGAACGCTGGCGGGTGATCGACGTCGTCGCCGACGTCGCGCGTACGCTGCACGCGCTTCCGGTGGCGGAGTGCCCGTTCGAGCGTCGGCTGGCCGACCTGATCCACCAGGCCAGCTCCTCGATGGCGCTGGGCGCGCTCGACCTCGACGACGTGGACCCCTCGCACGAGGGCTGGACGGCTCAGCAGCTCTGGGACGAGTTGAGCAAGATGACACCCCCGGCCGAGGACGACCTCGTCGTCTGCCACGGTGACTTCTGCCTCGACAACGTGCTGGTCGATCCGGAGACGCTGACCCTGGCCGGCATCCTCGACGTCGACCGGGCCGGGGTGTCGGACCGGTGGATGGACCTCGCCCTGGCGCTGTACAACATCGGCCAGGACGACGTCATGGGGCTACGGTCCGCCGCACGCCGAGCACTTCCTCCGGCGGTACGGCATCACCGTCGACCAGCACAAGCTGACCTACATCCAACTGCTGGACGAATTTCTCTGAGCTGA	MVAAPIPVAGWGDKDDPWECLGERSSGATVYRVGEVPSFYVKTTPPRHPDDHRFNPTKEAERLRWLAAQGLPVPEVVALDANDELAWVVTRALPGRPAARHWKPEERWRVIDVVADVARTLHALPVAECPFERRLADLIHQASSSMALGALDLDDVDPSHEGWTAQQLWDELSKMTPPAEDDLVVCHGDFCLDNVLVDPETLTLAGILDVDRAGVSDRWMDLALALYNIGQDDVMGLRSAARRALPPAVRHHRRPAQADLHPTAGRISLS	MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLTWLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF	102.27	gnl|BL_ORD_ID|634|hsp_num:0	687			39	684	neomycin; ribostamycin; paromomycin
BGC0000689.1|2-deoxystreptamine_5 # 2677 # 4011 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661	BGC0000689.1|2-deoxystreptamine_5 	2677	4011	+	Loose	1150	28.1054	tetB(46)	25.3	3004033	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAACTACCGTGAGTTGATCGAGCGGGCCCGGCGGACGACCGCGGCCGAGGAGTACGACATCTCGGGGCGCTATCCGTCGGTGATCGCGCACGCCGAGGGCGCCTGGATGACGGACCTGTCGGGCAACCGTTACGTCGACCTGACCGGCGCCGATGCCGCCGTCATCCTCGGCTACCGTCATCCGGCAGTCAATGAGGCGATCACGCGGCAGATTCGGGACTACGGTACGACGTTCGCGTCGACGTTGTCGGTTCCGCGGGTGGAGCTGGCGGACGGATGTGAGCGGTACGAGTGTGCGGAGAAGGTCGTCTTCCACAAAACTGGTACCGAGGGCACGGCGATGGCGGTCCGGTTGGCGCGAGCGGCGACGGGTCGGGAGTTGGTCCTGTCGTCCGGCTACCACGGCTGGCACGAGTGGCAGATGGCCGGGGAGGAGTTCGGGTACCAGCAGTCCACCGGTGTGGTGGGTTTCGGGTACAACGAGAAGGCCCTGGCGAAGATGCTGGAGGCGTTCGGTGAGCAGGTCGCCGGCGTCATCGTCTCGCCCGAGGTCCTGTACTTCGACCTCGATCACTACCGCCGGATGTCGGCGTTGTGTGCGCGGTATGACGTGCCGTTCATGTTGGATGAGGTGTACACCGGGTTCCGGGCGGGGCCGAAGGGCGTGCACGGGTTGGGTGTGCCGGCTGACGTCGTCGTACTCGGCAAGGGACTGGCGAACGGTCATTCGTTGGCGGCGGTGATGGGTCGTCGGGACATCATCGATGCGTATGACGTGTCGGGGATCCAGGGGACGTACACGCGGGAGGTGCCGCCGATGGCGGCGGCGCTCGCGGTGTTCGAGGTGCTGGACACGCCGGGTGTGTACGAGCACGCGGAGGCGATGGGTCGCCGGCTGGCGGACGGTATGCGCGAGATCCTCACCGGTGAGGGGATTCCGAACTGGGTGGGTGGCCCGGCCCTGATGTTCGACGTGGTGTTGCCGAATGACGATCTGGGTTGGGAGATCTACAAGACGGCGCACGACTTCGGGGTGTACTTCGAGGATTCCGGGACGCAGTTGGTGACGGCGGCGTTCGACGAGGCGGCGGTGGACCACGCGTTGACGGCGTTCCGGAAGGCGACGCGTCAGGTGGTCGCGGATCGGCCGGACATCGCGCCGACGTCGGGTGGTGAGTTGACGGAGGAGCGGAAGCTGGACTTCGCGGAGGAGGCCTTCGGTGGTCTGCTGCGTGACGACGAGCGGACGAACGCGTTGATCGACGAGACCATCGAGAAGGTGGTCAACCGGGACCGCAGCATCAAGCCGGTCCTCTTCCCGGCACAGAACTGA	MNYRELIERARRTTAAEEYDISGRYPSVIAHAEGAWMTDLSGNRYVDLTGADAAVILGYRHPAVNEAITRQIRDYGTTFASTLSVPRVELADGCERYECAEKVVFHKTGTEGTAMAVRLARAATGRELVLSSGYHGWHEWQMAGEEFGYQQSTGVVGFGYNEKALAKMLEAFGEQVAGVIVSPEVLYFDLDHYRRMSALCARYDVPFMLDEVYTGFRAGPKGVHGLGVPADVVVLGKGLANGHSLAAVMGRRDIIDAYDVSGIQGTYTREVPPMAAALAVFEVLDTPGVYEHAEAMGRRLADGMREILTGEGIPNWVGGPALMFDVVLPNDDLGWEIYKTAHDFGVYFEDSGTQLVTAAFDEAAVDHALTAFRKATRQVVADRPDIAPTSGGELTEERKLDFAEEAFGGLLRDDERTNALIDETIEKVVNRDRSIKPVLFPAQN	MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLYKVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRILLADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLSRQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQDPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDADQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE	76.82	gnl|BL_ORD_ID|2309|hsp_num:0	2644			534	777	tetracycline
BGC0000689.1|2-deoxystreptamine_6 # 4104 # 4475 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656	BGC0000689.1|2-deoxystreptamine_6 	4104	4475	-	Loose	900	24.2534	Corynebacterium striatum tetA	38.46	3004639	protein homolog model	n/a	n/a	penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCTCTGACGAAGCTCGGTCGGGCGGACACCCCGCCCGACCGATCCCTCGAAACATTCCCGATCGGCGACAGCTCGCAGGAGATCACCATCGACTGCCGGGAGTTCACCTGCCGCTGCCCCATCACCGGGCAGCCGGACTGGGCGACCATCCGGATCGAATACCGTCCCGGCGACCGGGGAGTGGAGACCAAGAGTCTCAAGCTCTACCTGGAGACCTTCCGGGACGAGGGGATCTTCCACGAGCACCTGGCGACGAAGATGCGTGACGACCTGGTGGCGGCCCTCGAACCGGTCTTCCTCAAGGTCACGGTCGACTTCAACGTCCGGGGCGGGATCGCGCTGGCAGCGTCGAGCACGTACCAGCGCTGA	MALTKLGRADTPPDRSLETFPIGDSSQEITIDCREFTCRCPITGQPDWATIRIEYRPGDRGVETKSLKLYLETFRDEGIFHEHLATKMRDDLVAALEPVFLKVTVDFNVRGGIALAASSTYQR	MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA	23.98	gnl|BL_ORD_ID|2120|hsp_num:0	3337			801	879	tetracycline; oxacillin; oxytetracycline
BGC0000689.1|2-deoxystreptamine_7 # 4483 # 5739 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GCCGG;rbs_spacer=15bp;gc_cont=0.691	BGC0000689.1|2-deoxystreptamine_7 	4483	5739	-	Loose	600	28.1054	BKC-2	36.07	3006223	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BKC Beta-lactamase	ATGACGCAGAAACTGGCCATCCTCGGTGGCGACCCCGTCCGGACCCGGCCCTGGCCCGAGTGGCCGCACGTCGGCCCGGAGGACGTGGATCGGCTGCGGACCGTCATCGAGAGCCGCAACCTCGGCGGCATCCCCTTCCCGAACACCATGCACCAGCAGTTCGCCGAGCGGTTCACCGCCAAGCTCGGGGCGAAGTACGGCCTCCTGGCGACCAACGGCACGGTGACCCTCTCGATGGCGCTGCGCGCGCTCGGGATCCATGCCGGTGACGAGGTGATCACCACCGCCTTCACCTGGGTCGGGACGGTCGCCGGCATCGTGCACGTCAACGCCGTGCCGGTGCTGGCGGACATCTCCGACGACAACTGGTGCATCGACCCGGTGAAGGTCGAGGAGGCGATCACCGACCGGACCAGGGCGATCATGGTGGTGCACCTGGGCAACCAGGTCGCCGACATGGACGCGCTGCTGGACATCTGCCGCCGGCACAACCTGCTGCTCATCGAGGACTGCGCGCACGCGCACTTCGCGGAGTGGCGGGGCCGGTGCGTCGGCACCATCGGCGACGCCGGCAGCTACAGCTTCGAGACCAGCAAGATCATGACCTCGGGCGAGGGTGGCTTCCTGGTCACCGCAACCGAGGAGGCGTTCCACCGGGCGATGTCCCTGGCGCACGTCGGCCGCAAGGAGGCCCCGTACGACAGGTTCCCGGGCCGGGTCTTCGGCTGGAACCACCGGGCCACCGAGATGCAGGCGGCCGTCCTGCTGGGGCAGCTCGACCGGTACGACGCCCTCGACAAGCAGCGGACCGCGATGGCGGAGATGCTGACCCAGGGGCTGGTCGAGATCGGCGGCTTCAAGCCGCTGGCGGAGGACCCCCGGGTCACCCGCCGGCAGCGTTACGAGCTGCTCTTCCGGTTCGACACCGAGGCCTGGGACGGGCTCCACCGGGACAAGGTGCTGGAGGCGATCCTCGCCGAGGGCGTCGAGTTCGAGGGGAACACCTTCTACCCGCCGATGCACCGCGACGAGCTGTTCCACATCACCGCCGACGACTGGCCGGCGATCCGGGAGCGCTACGGCGAGAAGATCGAGCCGGACGCGTTCCACCTGCCGGTGGCGGAGCGGGTGGCCTTCGACGAAGCGGTGTGGATCCACCACTCCCTGCTGTCGGTGGAGCCGGAGGACGTACAGGACATGCTGGATGCGGTGGTCAAGGTCCGGGACAATCTGGGGGCGCTGAAGAAGAGCCTATGA	MTQKLAILGGDPVRTRPWPEWPHVGPEDVDRLRTVIESRNLGGIPFPNTMHQQFAERFTAKLGAKYGLLATNGTVTLSMALRALGIHAGDEVITTAFTWVGTVAGIVHVNAVPVLADISDDNWCIDPVKVEEAITDRTRAIMVVHLGNQVADMDALLDICRRHNLLLIEDCAHAHFAEWRGRCVGTIGDAGSYSFETSKIMTSGEGGFLVTATEEAFHRAMSLAHVGRKEAPYDRFPGRVFGWNHRATEMQAAVLLGQLDRYDALDKQRTAMAEMLTQGLVEIGGFKPLAEDPRVTRRQRYELLFRFDTEAWDGLHRDKVLEAILAEGVEFEGNTFYPPMHRDELFHITADDWPAIRERYGEKIEPDAFHLPVAERVAFDEAVWIHHSLLSVEPEDVQDMLDAVVKVRDNLGALKKSL	MTITFSRRQAIAGALLAVPAVFTLAASAGAATGGLLEKRLAASAGAATGGLLEKRLAELEGRHKGRIGVAIHNLATGARIGHRADERFLMCSTFKALLAAHILARVDRKEETLDRRIVVGKSDLVDWSPVVETRVGGEGISIAELCEAAITLSDNAAANLLLSASGGPKAVTQFLRGFGDDVTRLDRTEPTLNYRETPDDERDTTTPAAMAETLRKLIIGDVLARGSKAQLAAWLVMNKTGDTRLRAGFPVDWTTGDKTGTNGDRHGNANDVAIAWSPDRGAVVVTAFCEIPGISGDERNAVIAEIGRIAAEA	133.55	gnl|BL_ORD_ID|3300|hsp_num:0	4369			162	345	
BGC0000689.1|2-deoxystreptamine_8 # 5739 # 7226 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.660	BGC0000689.1|2-deoxystreptamine_8 	5739	7226	-	Loose	800	29.261	msrA	23.15	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGGGCTTCTCGATCATGGGGTACAACCAGGTCATCCCGGCGCTGACCCTGGGCTACCTGATGAAGAAGGAGAACCCGGACCTCTACATCTGCTGGGGCGGCCCCTGGGTGACCTCCTTCGCGGACATGCTCATCCCGCGTCTGGAGGCCTGCCCCGAACTGGGTGAACTGATCGACGCCCTGGTCGTCCGGGAGGGCGAGGAGCCGCTGCTGAAGATGGCCGAGGCGCTGTCCCGGGGCGAGCGGCCGGTCGGTATCCCCGGCGGCTGCAAGCCGATGTCGGAGCAGAGCGTGCTCGACACCAAGCCGGTCGGCCGCAAGCTGCTGCTGGCGATGTCCCAGCCGCGGGAGAACATGCCGAACACCCACTGGCGGATCGAGGACGGCACCTACGAGCGCAGCGGTGACATCTCCTGGGTCGCCGACATGAACCAGCTCCCGACCCCGGACTACAGCGACTTCGACCTGTCGCTGTACACCACCTTCCGGGAGGGTCAGGGCAGCCTCGTTCTCCAGGGCTCGCGGTCCTGCTACTACATGAAGTGCTCGTTCTGCAACGCGATCACCAACTTCGCGCCGTGGAGCTACCGGGAGCGCAGCACCGAGAACATCCAGAAGGACATCGACACCTTCCTGGAGCTGTACCCCGGGACCGTGCACTTCGACTTCGCCGACGCGGTCTTCCCGGCGAAGCGGCTGGTCGAGCTCGCCGACTTCTTCATCGCGAAGAAGCGCCCGGAGCTGTTCTGGGAGGTCGACGTCCGGTTCGAGGGCAACATCGACAAGGCCGTCCTGACCAAGATGCGCGACTCGCAGGGCACGCTGCGCTTCGGCCTGGAGACGGCGAACGAACGTCTCCTCGACCTGGTCCGCAAGGGCAACCGGATGGAGGTCGTCCACCGGCTGCTCCAGGACAGCCGGGAGCTGGGCTACAAGCCGTTCCTGATGACCATCGTCGGCCTGCCCACCGAGGAACGGGAGGAGGCCGAGGAGCTCTACCAGTTCCTCAGCGACTACCACGACACGGTGACGTACCAGATCGCCGACTTCATCGTCGAGCGGAACTCGCCGATCCAGCTCCGGCCGGACGACTACGGCATCCACATCGACGACGACGAGCAGGAGAGCTTCCACCACAACCTGCACTTCACCCGCCGCGCCGGCTACAGCGACGAGGAGGCGCAGGAGGTGTACCGGGACATCCTGGTCCGCACCATGCAGCGGTTCAAGGGCGCTCACGAGGTGGACGTGGAGCAGGAGCGCAGCCGGGTCGCCCCGGACGACTCCGTGTACCGGCTGAGCCTGCGGGCCGGCTCCTTCGCACTGGAGAACTACTGGGTGAAGCACAACAACCTGCCGTTCGAGGGCCTGGTGCCGATCGGCTACAAGGTCCAGCAGCAGTGGACCGACATGACGGACAAGGGCACGGTCTTCGAGATCGACCCGGACATCGCCCTCGGGGCCCTCGCCGGGGCAGGTAGCCGCTGA	MGFSIMGYNQVIPALTLGYLMKKENPDLYICWGGPWVTSFADMLIPRLEACPELGELIDALVVREGEEPLLKMAEALSRGERPVGIPGGCKPMSEQSVLDTKPVGRKLLLAMSQPRENMPNTHWRIEDGTYERSGDISWVADMNQLPTPDYSDFDLSLYTTFREGQGSLVLQGSRSCYYMKCSFCNAITNFAPWSYRERSTENIQKDIDTFLELYPGTVHFDFADAVFPAKRLVELADFFIAKKRPELFWEVDVRFEGNIDKAVLTKMRDSQGTLRFGLETANERLLDLVRKGNRMEVVHRLLQDSRELGYKPFLMTIVGLPTEEREEAEELYQFLSDYHDTVTYQIADFIVERNSPIQLRPDDYGIHIDDDEQESFHHNLHFTRRAGYSDEEAQEVYRDILVRTMQRFKGAHEVDVEQERSRVAPDDSVYRLSLRAGSFALENYWVKHNNLPFEGLVPIGYKVQQQWTDMTDKGTVFEIDPDIALGALAGAGSR	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	101.43	gnl|BL_ORD_ID|1105|hsp_num:0	1200			144	456	erythromycin; quinupristin
BGC0000689.1|2-deoxystreptamine_9 # 7352 # 7720 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.615	BGC0000689.1|2-deoxystreptamine_9 	7352	7720	-	Loose	800	26.1794	mef(B)	37.84	3003107	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGTCACTAACAAGATCGTCACCGGTGTCGCATTCCCACCGTCGTTGTTGGCGGAGACCCCGCCGATCTCGGTGGCGACCCTCACGGCCTACCTTCGCGACAAGGGTATGCCGGCTGTCGGCCTGGACCTGAACGCGGACTTCAACGAGTACCTGCTCAACCGGGTCGAGATCGAGCAGGTGCAGGGCCCGGGAGAACACCCACGAGTTCACCAAGCCCTTCATCAAGCAGTTCTTCCTGAACCACATCACCGGGAACTACTTCACCGAGACGAACTTCGAGCAGTGGGACCTGCAGCAGCAGTGCCAGGTGGCGCCGGAGAGCCTCTCCATCTGGGACCCGCCCTTCCCGTTCTCGTACTGTGA	MTVTNKIVTGVAFPPSLLAETPPISVATLTAYLRDKGMPAVGLDLNADFNEYLLNRVEIEQVQGPGEHPRVHQALHQAVLPEPHHRELLHRDELRAVGPAAAVPGGAGEPLHLGPALPVLVL	MNRIKNWKKQFAVIYTGQAFSILGSAAVQFAVIWWLTIQTESAITLTIASLVAFLPNMLIGPFAGVWIDRYNRRTVMILADGLVAVSSIILGAAFLLVETPPIWFIYIVLFLRGLGNTFHGPAMQAAIPMFVPADMLTKAGGWGNMIQSISNMMGPVLGAALMSFLPISSIMIVDILGAAFAIVCLLFVIIPDITQTNEKMSVLSDMKQGFIAMKANKPLMAVFSPMLLMTILYMPLGSLFPLLARSHFMGEAWHNSIVEFVFAGGLLLSSLVIGVWGGMKRRFFMASLAIGLMGLATLISGALPTSGFWIFVICCFFLGASGTFMNVPVMAYVQESIAPEMMGKVFSLLMTAMTLSMPIGLLVAGPVVEVIGVNTWFFWSGVALIVNAVLCRILTRRYDKVTMKPQVD	29.83	gnl|BL_ORD_ID|1198|hsp_num:0	1198			246	348	
BGC0000689.1|2-deoxystreptamine_10 # 7722 # 8990 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000689.1|2-deoxystreptamine_10 	7722	8990	-	Loose	700	28.4906	vanS gene in vanE cluster	26.44	3002935	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGCCTGACAACAAGGCCCCCCGGGGCGTCCTCTCGCTGACACCGTTCTTCCTCTACGCCGATCACCAGAAGCTGTGGAAGCCACGGTTCGACCCGATGGGCGGCATGCACGTGTTGGGCCACGCGATCGTGACGGAGATGGGCCGGCGGGGCTTCCCGCAACGGGTCCTCACCATGGCCCCGCCCGGCGTCCCGAAGGACCTCCAGATCGCCCCGAACGTCACCGTGCACGCCCGGCGACTGCCGGTGCTGCCGATCCCGTCCAAGCTGGAGGGTTACTTCGGCCTGGTCGGGGCATGGGCGAAGGCCAGCCTGCTCTACGTGATGCGCAACAAGGAGCAGCTCAAGCGCGAGATCGGAATCGTGCACGCGCACTGCGACGGTTCCGGATCCGCCCCGGCGTACGCGTACGCCGCGGCGCAGGTGCTCGACGTGCCGATCGTGTCGCACATCTACTCCTGCCGGTCGCTCACCCAGCACCCGACCACGGTGTTCGAGCGGGTGGTCGACCCGGTGGCGAAGTCGGCGGAGAAGTACGTCATCCAGCACTCCGGCGCCGTGCTCACCCTCAGCGACAAGGTGCGCGAGCGGATCCGGGACGAACTGCACGTGCCGGACGACAAGGTGCACCGGCTGGCGCACCTGGTCACCGACAACTTCGTCGGGCACGACACCCCGGAGCGCCGGGAGGAACTGCGGCAGCGGTTCGGGCTGACCGACGACAAGCCGACCGTCCTCTACGTCGGCCGGATCTCGTCCGAGAAGGGCGTGGACTGGTTCGTCAAGGCCGCCGCCGAGGTCGCGAAGCGGCGCGACTGCCGGTTCCTGATCGCCGGGGACGGCCCACAGCGCGGCGACATCGAGGCGCTGGCCCGCCAGCTCGGCGTCGCCGACAAGCTGGTCATCACCGGCTTCCTGCTCCCCGAGTACATCCCGTCGATCATCTCGCTCTCGACGCTGGCCGTCCTGCCCTCGCAGTACGAGGAACTGGGCGTCGTCGTCCTGGAGTACATGATGATGAAGCGCCCGGTCGTGGCGCACGACGTCAGCGGCGTCCACAAGCTGGTCGACCACATGAAGACCGGCGTCCTGGTGCCGCCCTTCGACCCTCCGAAGCTCGCCGATGCCATCGAGATGGTTCTCGACGATCCGGACCTGGCCCGTCGCCTCGCGGAGAACGCCGAACCGATTCCCCAGCGGGAGTACTCGCTGGCCTCGGCCGGTGAACGCCTCGAGGCGATCTACCTATCCCTCATGGAGGAGTCCTGA	MPDNKAPRGVLSLTPFFLYADHQKLWKPRFDPMGGMHVLGHAIVTEMGRRGFPQRVLTMAPPGVPKDLQIAPNVTVHARRLPVLPIPSKLEGYFGLVGAWAKASLLYVMRNKEQLKREIGIVHAHCDGSGSAPAYAYAAAQVLDVPIVSHIYSCRSLTQHPTTVFERVVDPVAKSAEKYVIQHSGAVLTLSDKVRERIRDELHVPDDKVHRLAHLVTDNFVGHDTPERREELRQRFGLTDDKPTVLYVGRISSEKGVDWFVKAAAEVAKRRDCRFLIAGDGPQRGDIEALARQLGVADKLVITGFLLPEYIPSIISLSTLAVLPSQYEELGVVVLEYMMMKRPVVAHDVSGVHKLVDHMKTGVLVPPFDPPKLADAIEMVLDDPDLARRLAENAEPIPQREYSLASAGERLEAIYLSLMEES	MKNNLTVQITKKYFYTMIIITTILVILPLVAKMFLSLRVWQGTEFFYPILYILNRSLGVWLIVTPLFIWLIVTYMFFRKMISYLEEMIVATKSLIETPNEKIVLRVELAEFENEINHIRIDSLENKKMAEEAGKKRDDLLTYLAHDLRTPLTSIIGYISLLQNEQTYLELDSTKRKNYIDIISDKANRLEHLLNDFFEIAKTGKSREEVYKEEVDLSLMLSQISSEFLPLLDEKKLEWDFKIEPNVFVQLNINKFERVLDNLIRNAISYSLNDTTIKLTLEKVDEKVVVSVGNITDKVSEKDIDQLFEPFYRGDKSRNTKTGNAGLGLAIAKQIISEHGGTIEAELQNNDFKVSIIL	118.21	gnl|BL_ORD_ID|1504|hsp_num:0	1571			477	714	vancomycin
BGC0000689.1|2-deoxystreptamine_11 # 8983 # 10008 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000689.1|2-deoxystreptamine_11 	8983	10008	-	Loose	400	25.7942	QnrS8	25.0	3002797	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGGTTGAGCGCCTGGGCGTCGCCGTAGTCGGCGGCGGGTTCATGGGTGGCGTGCACGCCGAGGTCCTGACCGCCGATCCCCGAGTGGATCTGCGGTGGGTGGTGGACCGCGACGAGCGCGTCGGCACGGACCTGGCCACCCGGTTCGGCGCACGCGTCACCACGACCCTCGACGAGGCGCTGGCTGACGACACGGTCCGGTTCGTGGTGGTGGCCACTCCGGCCGCCACCCACGAGCCGATCGCGGCACAGGTCATCGCCGCCGGCCGGAACGTCCTGGTGGAGAAGCCGCTCGTGCTCTCCACCGGGCACGCCCGGCAACTCGCCGCCGCGGCCCACGAACGCGGGGTGGTCCTCGCGCACGGTGGCAACTTCGTCTACGCCCCGAAGTTCGTCCGGGCTCACGAGCTCGCGGCCGACCGGGAAGCACTGGGCACCGTCCACTCCGTCCGGGTAGCCTTCCGGACGTCCGGACCGGACACCGACTGGTTCCGGTCGAAGGCGACCGCCGGTGGTGGCGCCCTGACCGACCTCGGCTGGCACGCGGTCGAGCTGTGCCGCTGGATGCTCGGCAAGCCGGCCATCCGCGCGGTCACCGCCTGCACCCGGCAGCTCAGTGCCGCCGGGGACGTCGAGGACCAGGGTGTCGTCCTGATCGAGTTCGCCGACGGCGCGATCGGTCAGTGCGACGTCTCCTGGGCCTGCCCCGGCGGTGAGCAGCTCACCGTCGAGGTGATCGGCACGGAGGGCCTGGTCACCGCCGATCTCTGGCAGGGCATGGGGGTCGAGGCCTACACCAACACCAAGTTCGGCGCGGTGTGGGAGCCCAACCAGGGATGGCTGCGCCCCGAGTGGGAGTGGATCCGCAACAGCGGATACGTGCACCAGGACCGTCAGGTCGTGGACGCGGTGCTCGACGGGCGGCCCATGACGCACACCCCGGACGACGCCGTCGCGGTCGTCGAAACGCTCGAAGCGGCGTACCGCAGCGCGGCCGACGGGCGGAAAGTGGAGATGAATGCCTGA	MVERLGVAVVGGGFMGGVHAEVLTADPRVDLRWVVDRDERVGTDLATRFGARVTTTLDEALADDTVRFVVVATPAATHEPIAAQVIAAGRNVLVEKPLVLSTGHARQLAAAAHERGVVLAHGGNFVYAPKFVRAHELAADREALGTVHSVRVAFRTSGPDTDWFRSKATAGGGALTDLGWHAVELCRWMLGKPAIRAVTACTRQLSAAGDVEDQGVVLIEFADGAIGQCDVSWACPGGEQLTVEVIGTEGLVTADLWQGMGVEAYTNTKFGAVWEPNQGWLRPEWEWIRNSGYVHQDRQVVDAVLDGRPMTHTPDDAVAVVETLEAAYRSAADGRKVEMNA	METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD	156.42	gnl|BL_ORD_ID|212|hsp_num:0	234			51	231	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000689.1|2-deoxystreptamine_12 # 10001 # 11194 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0000689.1|2-deoxystreptamine_12 	10001	11194	-	Loose	200	28.1054	vanH gene in vanM cluster	34.09	3002947	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGGAGGTCGAGATACGCCTGGGCTCGGTTCGGTATCCGTTCCGGCTCGGCACCGACTGCCTCGGTGCCATCGTGGAAGACCTGGTCGCCATGTCGGCCAGTCGGCTCCTGATCGTCTGTGACAGCAACACCGGTCCACTGTTCGGCGCGGAACTGGTCGAACGGCTCTCCCCACGGGTTCCGGCGAACCTGCTCATCCACCGCGCCGGTGAGCCGTACAAGGATCTACAGGCCGTCGGCACGTTGGCCGACTCGGCGCTCCAACTCGGCGCGGACCGCGCCTCGGTGGTGGTCGCCGTCGGCGGTGGCGTGATCGGCAACATCGCGGGCCTGATGGCCGCCCTGCTCTTCCGCGGGATCCGCCTCGTGCACATCCCGACGTCGCTCATCGCGATGTCCGACTCGGTCCTCTCGCTCAAGCAGGCGGTCAACGCCTGCGTGGGCAAGAACCTGATGGGGACCTTCTACGCGCCGGAGTCCGTCCTGGCCGACACCGCCATGCTGCGGAGCCTGCCGTTCCGGGAGACGGTCTCCGGCCTCTGCGAGGTCGTCAAGAACTCGCTGGCCATCCGGCCCAGCATGGTCGAGATGCTCCGCACGTCGCTGCGGCAGGACGCCGTCTACGACGACGAGACGATGTACGAGATCATCTCCGAGAGCATCCTGGCGAAGGCCTCGGTGACCGTGGACGACATGCACGAGTGCCGCGCCGGTCTCGTGCTGGAGTACGGCCACACGGTCGGACACGCCATCGAGTACACCGCCGCCGGCGGGCTCTCCCACGGCCAGGCGATCGGCCTCGGCATGGTGGTGGCCGCCGAGGTGTCCCACCGGCTGGGTCACCTCGACCAGGAGGCGGTCGCCCTGCACCGGGAGCTGTTGACCCGGGCGGGCGCGATGGTGACCATCCCCGAGGAGGTCGACCTCGACGAGGTGATGCACCGGCTGCGGTTCGACAACAAGCGCGGCTACCTCGCCGACCCGGCCGAGAGCAGCGCGATGGTCCTCCTCGGTGGACTGGGCGAGCCGCTGTGGCACGACGGGCGCCCGCTGGTCTCCGTTCCGATGGCGCTGGTCGGCGAGGTCGTCAACGAGATCGCCCGTCCGGAGATCCCGAACTTCGAGTTGGTGGCTCCGGTCGAGACGGTGGAGGAAGGCCGGGTGCCGGACACGGTGGGTGCTGCCGATGGTTGA	MEVEIRLGSVRYPFRLGTDCLGAIVEDLVAMSASRLLIVCDSNTGPLFGAELVERLSPRVPANLLIHRAGEPYKDLQAVGTLADSALQLGADRASVVVAVGGGVIGNIAGLMAALLFRGIRLVHIPTSLIAMSDSVLSLKQAVNACVGKNLMGTFYAPESVLADTAMLRSLPFRETVSGLCEVVKNSLAIRPSMVEMLRTSLRQDAVYDDETMYEIISESILAKASVTVDDMHECRAGLVLEYGHTVGHAIEYTAAGGLSHGQAIGLGMVVAAEVSHRLGHLDQEAVALHRELLTRAGAMVTIPEEVDLDEVMHRLRFDNKRGYLADPAESSAMVLLGGLGEPLWHDGRPLVSVPMALVGEVVNEIARPEIPNFELVAPVETVEEGRVPDTVGAADG	MVLVMKDIGITIYGSEQDEADVFQEISSRFGVTPTIVSSPISETNVMLAPKNKCISVGHKSEIHKSILIALKESGVKYISTRSIGYNHIDMKAAEKMGIAVENVTYSPDSVADYTLMLILMAIRHTKSTLCSMEKHDFRLNSVRGKVLRDLTVGVLGTGHIGKAVIERLQGFGGHVLAYGNNKEATANYVSFNELLQKSDILTIHVPLSDDTYHMIGHEQIKAMKQGAFLINTARGGLIDTEVLVKALEDGKLGGAALDVLEGEEGLFYFDCTQKPINNQFLLKLQRMPNVTITPHTAYYSEKTLRDTVEKTVKNCLEFERRETHE	121.78	gnl|BL_ORD_ID|4743|hsp_num:0	1724			315	447	vancomycin; teicoplanin
BGC0000689.1|2-deoxystreptamine_14 # 12886 # 13710 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.650	BGC0000689.1|2-deoxystreptamine_14 	12886	13710	+	Loose	500	482.256	sgm	89.78	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGACGACATCTGCGCCTGAGGACCGTATCGACCAGGTCGAGCAGGCCATCACCAAGAGCCGGCGCTACCAGACGGTGGCCCCGGCCACCGTGCGGCGCCTGGCCCGGGCTGCCCTCGTCGCCGCGCGGGGCGACGTGCCGGACGCGGTGAAGCGCACCAAGCGCGGGCTGCATGAGATCTACGGGGCCTTCCTGCCGCCCAGCCCGCCCAACTACGCAGCGTTGCTGCGGCAGCTCGACTCCGCTGTGGACGCCGGTGACGACGAGGCGGTCCGGGCGGCTCTGCGCCGCGCGATGTCAGTGCATGTGTCCACTCGTGAGCGATTGCCGCACCTGGCGGAGTTCTACCAGGAGATCTTCCGTCACGTGCCCCAGCCCAACACGCTGCGTGACCTCGCCTGTGGCCTCAATCCGCTGGCCGCTCCCTGGATGGGCCTGTCGGACCAGACCGTCTACGTCGCCTCCGACATCGACGCCCGGCTGATCGGCTTCGTGGACGCCGCCCTGACGAGGCTGGGCGTCGCGCACCGTACGAGCGTGGTCGACCTCCTCGAGGACCGCCTTGACGAGCCGACCGACGTCACGCTATTGCTGAAGACGCTGCCCTGTCTGGAGACTCAGCGACGAGGCTCCGGCTGGGAAGTGATTGACATTGTCAACTCGCCGATTATCGTGGTAACCTTCCCGACCAAGTCTCTCGGTCAGCGATCGAAGGGGATGTTTCAGAACTATTCACAAAGTTTTGAGTCCCAGGCCAGAGAACGGTCGTGCCGAATTCAGCGACTGGAGATCGGCAACGAGCTGATTTACGTCATTCAGAAATAG	MTTSAPEDRIDQVEQAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRQLDSAVDAGDDEAVRAALRRAMSVHVSTRERLPHLAEFYQEIFRHVPQPNTLRDLACGLNPLAAPWMGLSDQTVYVASDIDARLIGFVDAALTRLGVAHRTSVVDLLEDRLDEPTDVTLLLKTLPCLETQRRGSGWEVIDIVNSPIIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	100.00	gnl|BL_ORD_ID|1906|hsp_num:0	2079			0	822	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0000689.1|2-deoxystreptamine_15 # 13747 # 14994 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=CGGAA;rbs_spacer=15bp;gc_cont=0.716	BGC0000689.1|2-deoxystreptamine_15 	13747	14994	+	Loose	700	50.0618	LpsB	22.08	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGTGTACTTCGGCTGACTCCCTTTTTCCACCACGACTACGTCGACCACTGGCCGGCCGAGTTCGATCCGGTGGGCGGTATGCAGGTGCAGATCCTGGCGTTGTCCCGCAGCCTGGCCAGGGCGGGCGTCGACCAGCTCGTGCTGACCCTGGGCTTTCCGGGGTTGCCGCCGACGAAGCAGATCGAGCCGGGCCTGACCGTTCGTATCGCCCGGGTGTCCCTGCCCCAGATCCGTTCCGAGATCACTGGATTGGTCGGCCTGGGACAGGCATGGTTGATCGGAACCATCCGGGAGTGCCTCCGGTTGCGTCGCGGTGACTGGCGCCCCGATCTCGTCCACGTGCACGCCGACGGCCAGATCTGGCCACTGGTCGCGGGTCGGATCGCCGCCCGGATCCTGGGCGTGCCGTACGTGCTCACCCTGCACTGCTCCCGGCTCTCCGTCTACCAGCCGATGTCGGCGGTGGACGCGATGGCGCACCGCCTGGTCACCCAGGCGGAACGACAGGCGCTGCGCTCCGCCGCCCGGGTCAGCACCCTGACCGCCCGCACCGCCGACGTGGTGAGCGCCGCGACCGGTCTGGACCGCTCTGCCATCGTGGTCAACCCGGACGCGGTCGACATCACCCCGGCCACGCCCGCCGAGGCGGCGGCGTTCGCGCAGCGGTACGGCCTGACCGGCCGCCGGCCGCTCATCGGCTACATCGGCCGGGTCGCCCACGAGAAGGGCTGGCCGGACCTGCTCCGCCTGGCCGAACTTCTGGACGACCTCTCCCCGACCTTCCTCGTCGTCGGTGACGGCCCCCAGCGGGAACGGATGGAACGGGAGATCGCCGAGGCCGGTCGCGCGCACCAGTTCGTGGTGACCGGTTTCCTCCCGCACGACCAGGTGCCGGCCGCTCTCGCGCTGGTGGACACCCTGGTCATGCCCTCGATCCACGAGGAACTCGGGGGCAGCGCGATCGAGGCGATCATGACGGGCACCCCGGTCGCCGCCTACGCGGTCGGGGGACTGCGCAGCACCATCGGCTCGGCCTGCCCCGACCTGCTCAGCGAGCCCGGCGACGTACGCGGACTCGCCGACGTCGTCCGGCACGTCCTGACCGACCGGGACGCGGTGGTCGCGCAGATCCACGCCGCGCAGACCAGCACCGCCAGCACCTTCGACGTCGCCGCCACCCGGGACCGGATGATCGACTGCTACCGCGCCGCCCTCGCCGGGGCCGGGGCGGCGAGCGGGAAGTGA	MRVLRLTPFFHHDYVDHWPAEFDPVGGMQVQILALSRSLARAGVDQLVLTLGFPGLPPTKQIEPGLTVRIARVSLPQIRSEITGLVGLGQAWLIGTIRECLRLRRGDWRPDLVHVHADGQIWPLVAGRIAARILGVPYVLTLHCSRLSVYQPMSAVDAMAHRLVTQAERQALRSAARVSTLTARTADVVSAATGLDRSAIVVNPDAVDITPATPAEAAAFAQRYGLTGRRPLIGYIGRVAHEKGWPDLLRLAELLDDLSPTFLVVGDGPQRERMEREIAEAGRAHQFVVTGFLPHDQVPAALALVDTLVMPSIHEELGGSAIEAIMTGTPVAAYAVGGLRSTIGSACPDLLSEPGDVRGLADVVRHVLTDRDAVVAQIHAAQTSTASTFDVAATRDRMIDCYRAALAGAGAASGK	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	113.39	gnl|BL_ORD_ID|2781|hsp_num:0	3793			36	1095	colistin A; colistin B; defensin
BGC0000689.1|2-deoxystreptamine_16 # 14991 # 15818 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GCCGG;rbs_spacer=15bp;gc_cont=0.766	BGC0000689.1|2-deoxystreptamine_16 	14991	15818	+	Loose	275	26.1794	AAC(6')-I-48	38.71	3004638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGACCGGGCAGCGGAGCATGGACACCGCCCCGGCGAACACGCACGTCCGCCCGAGGCGGGGGCACGTCCTGGTGACCGGCGGGAACCGGGGCCTCGGGCTGGCCACCGCCACCCTCCTGGTCGACGACGGCTGGTCCGTCCTGCTCGGGTGCCGCGACGAGCGGCGGGGCGCGGCGGCCGCCGAGGCGCTGCGCCGTCGGGGCGGCCGGGCCGCACACGTACCCCTGGAGGTGACCTCACCGGCGAGCATCGCGGCTGCGGTCGACCTGGTCGCCGACCGCACCGGCGGGCGCCTCGCCGGCCTGGTCAACAACGCCGGGGTCTTCCTCGACGAACGCGACGCCGACCTGGAGAGCGTGACCGCCGAGGCGGTCCACGAACTGCTCGCCGTCAACGCCGTCGGTCCCCTGCTGGTGACCCGCGCCATGGTGCCGCTGCTGCGAGCCGCGGCGGGGGCCGCCGTGGTCAACGTGACCGCCGACGACGCCGACCCGGCCACCGCCGACGGGGAGGCCACCGGCTACCGGATGTCCAAGGCCGCGCTGAACATCATGACCGTCAACCTGGCGGTCGCCCTGCGCGAGCAGGACGTCGTCGTCAACGCGGTCGACCCGGGCTGGATCCCCACCGACATGGGCGGCCCGGAGGCGCCCGACGACACCGCTGCCGCCGCGCGCCTGGTGGCCTGGGCCGTCACGGCCGCCCGGGAGCACGGGACCACCGGGCAGGTGCTCAGCGTCCGGCAACCCCCCGACGGGCTGCGGGCCGACCCCGTGACCGTCGGCGCACCCCCGACCGTCGTACCCCCGCACGGACAACCCCAGTGA	MTGQRSMDTAPANTHVRPRRGHVLVTGGNRGLGLATATLLVDDGWSVLLGCRDERRGAAAAEALRRRGGRAAHVPLEVTSPASIAAAVDLVADRTGGRLAGLVNNAGVFLDERDADLESVTAEAVHELLAVNAVGPLLVTRAMVPLLRAAAGAAVVNVTADDADPATADGEATGYRMSKAALNIMTVNLAVALREQDVVVNAVDPGWIPTDMGGPEAPDDTAAAARLVAWAVTAAREHGTTGQVLSVRQPPDGLRADPVTVGAPPTVVPPHGQPQ	MSKLGPTKPAPSMANTPVGNVVPCKTPDHPGWLELRLQLWPDGSTEEFLPEMAAACAEPDRFGQFLFLSPGGLAEGLVEVALRTDYVNGTESSPVAFLEGVFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAEVSNVGSHAMHAALGFVETERVVFFRKVVAP	164.67	gnl|BL_ORD_ID|4965|hsp_num:0	3338			300	393	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000689.1|2-deoxystreptamine_18 # 17546 # 18799 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000689.1|2-deoxystreptamine_18 	17546	18799	+	Loose	500	29.6462	OXA-830	28.0	3006027	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCATCGACATCGGTGCCGGCAAGCTGCTGGCCCAGGAACCCACCTGCCCCCGGGACGCCGACGGACGCCCCCGGGTGTTCGTCGAGGGCTCGGGCGCGTACCTGACCGACCCGGACGGCCGCCGGTGGATCGACTTCGACAACGCCCGGGGATCGGTCGTCCTCGGCCACGGTGACGAGGAGGTCGCCGAGGCGATCGCCCGCGCCGCCCGGGGCCGCTCCGGGGTGGGCACCGCCTGGAGCCCGGTGCTGGACTCCCTGCTCGGTCAGTTGCAGGAGGTGTGCGGCGGCGACGTGGTCGGCCTCTACCGCACCGGCACCGCCGCGCTCCGCTCGGTGACCTGCGCCGTCCGGGACGCCCGGGACCGGTCGATCGTCCTCAGCTCGGGTTACCACGGGTACGACCCGATGTGGCACTGCGACGAGCCTTTCACCCCCAACCAGCACGGCATCGTCGAGTTCCTCTTCGACCTGGACGTGCTCGCCGAGTGGCTCAGCCGCCCGGAGCAGGTGGCGGCGGTGGTCATCAGCCCGGACCACATGCACCTGGGCGAGCGCTGGTACACCGAGTTCACCCGGCTGACGAAGGAGGCGGACGTCCCGGTCATCGCCGACGAGGTCAAGGTCGGCCTCCGCTACCGGGCCGGGCTCTCCACCCCCCTCCTCGACCCGGCCGTCTGGATCGTGGCGAAGTGCCTGGCCAACGGCTCGCCGGTCGCGGCGGTGGGCGGGGACGCCCACCTGCTCGCCGCGCTGGAGGACGTCTCGTTCACCTCGTACTTCGAGCCGACCGCCATGGCCGCCGCGACCACCACGCTGCGGCGGATGGCGACCGGGGAACCGCAGCAGGCCATCCGGGCCGCCGGTGACCGGTTCATCGCCCACACCCGGGCGGCGTTCGCCAACGCCGGAGTCCCGATCGACCTCGCCGGCAACGGCAACCTCTTCCAGTTCGTCTGCGCCGACGACGAGGTGGCCGACGCCTTCCACGCCGCCGCGGCGGCCGAGGGGCTGCTCTTCTTCGAGGGCGACAACCAGACCCCCTCGGCGGCGTTCACCGACGAGGTGGTCGAGGACGCGTGCGGCCGGATCGACCGGGTCAGCGCCGCGCTGACCGGCCGCTTCACCGACCGCGAACTGACCGAGGAGTCCTGGTACGCCAGCGCCTGGGGCGCGATGGACGGTCTGGCGGACCGGCCGCGCACCCGGGAGGAGACCACCGCGATCGTCGAGCGCCTCTGGGAGGACTGA	MTIDIGAGKLLAQEPTCPRDADGRPRVFVEGSGAYLTDPDGRRWIDFDNARGSVVLGHGDEEVAEAIARAARGRSGVGTAWSPVLDSLLGQLQEVCGGDVVGLYRTGTAALRSVTCAVRDARDRSIVLSSGYHGYDPMWHCDEPFTPNQHGIVEFLFDLDVLAEWLSRPEQVAAVVISPDHMHLGERWYTEFTRLTKEADVPVIADEVKVGLRYRAGLSTPLLDPAVWIVAKCLANGSPVAAVGGDAHLLAALEDVSFTSYFEPTAMAAATTTLRRMATGEPQQAIRAAGDRFIAHTRAAFANAGVPIDLAGNGNLFQFVCADDEVADAFHAAAAAEGLLFFEGDNQTPSAAFTDEVVEDACGRIDRVSAALTGRFTDRELTEESWYASAWGAMDGLADRPRTREETTAIVERLWED	MTPILLRGLLAAGLLFALPAAANDGCFLFADGSGKTLSREGACSMRLPPASTFKIPLALMGYDSGYLVDEQRPALPFKPGYNGWLPAWHETTTPSRWMTYSVVWFSQLMTEWLGMPRLQHYVDQFDYGNRDLSGHPGKQDGLTQAWLSSSLQISPEEQARFLGRMLEGKLPVAASTLQHTANLLKVSEIDGWQIHGKTGMGYPKKLDGSLNRQRQIGWFVGWASKGSERRIFVHTVIQPPGKQFASLKAKEEVLAALPAKLAEQAN	156.77	gnl|BL_ORD_ID|4062|hsp_num:0	5132			204	348	cloxacillin; oxacillin; cefalotin
BGC0000689.1|2-deoxystreptamine_19 # 18813 # 19730 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000689.1|2-deoxystreptamine_19 	18813	19730	-	Loose	500	117.472	sgm	31.78	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGACGTCGACCCCGCCGGGCCTGGTGCCGGCCGGTGAACCGGCACCGGCCACCCGGCCGGAGCCGGAGTCGGCCATCCTGCCGGAGCCGGCCGCGGCCGTGCCGTCGCCGCCGCCGGAGTCACCCGCCGTGCAGAAGGTGATCGCCCGGCTCACCGCCGCGGCCAAGTACCGTGACGTGCACCCGGAGACCGTCGCCGACCTGGTCCGGCGGGAGGGTCGGGCCACCGGGGACGCCGCCGAGCTGGAACGGCGGGTCCGGGCCCGGCTGCACAAGGTCGCCGCCCTGCACCTGCTCACCGCCCGGCCGGCGGCGCTGCGCAAGGCGCTGGACCGGGCCGACCTCGACGACCCGCAGTCCCGGCGGGACTGGTGCCGGCAGGTGCTGGCCGGGCACTTCTCCACCGCCGAACGCCTGCCCGACCTGGACACCTTCTACCCGACCCTGTTCGGGCTGGTGCCGCCGCCGGAGACGGTGGCCGACATCGCGTGCGCGCTGAACCCGTTCACCGTGCCCTGGCTGCGGGAGGTGAGCGACGCCCGCTACGTCGGCTACGACTTCAACGCGACGTTCGTGGAGCTGGGCAACGCGTTCCTCGCCCGGACCCATCCGGAGTGCGAGATCCGGCACGAGGAGGTGCTCACCGACGGCCACCGGGTGAGCGCTGACCTGGGGTTGCTGCTCAAGACGTACCACTGCATGGAGGGACGCCGGCCCGGCGCCGGGCTGGCGCTGGTCGACCGGCTGGCGTGCCGGCACGTGGTGGTGTCGTTCCCCACCCGGGCCATGAACGGCCGGGCGGCGGTCTTCGTGCCCCGTCACGTGGAGGAGCTGGCCGAGCTGGCCCGCGACCGGGGATGGAGCTGGTCGCGGGCCACTCTGGCGTCCGAGGACCTGGTGGCGATCCACAAGGAGTGA	MTSTPPGLVPAGEPAPATRPEPESAILPEPAAAVPSPPPESPAVQKVIARLTAAAKYRDVHPETVADLVRREGRATGDAAELERRVRARLHKVAALHLLTARPAALRKALDRADLDDPQSRRDWCRQVLAGHFSTAERLPDLDTFYPTLFGLVPPPETVADIACALNPFTVPWLREVSDARYVGYDFNATFVELGNAFLARTHPECEIRHEEVLTDGHRVSADLGLLLKTYHCMEGRRPGAGLALVDRLACRHVVVSFPTRAMNGRAAVFVPRHVEELAELARDRGWSWSRATLASEDLVAIHKE	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	111.31	gnl|BL_ORD_ID|1906|hsp_num:0	2079			48	822	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0000689.1|2-deoxystreptamine_20 # 19738 # 20898 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000689.1|2-deoxystreptamine_20 	19738	20898	-	Loose	1200	26.1794	LRA-13	32.43	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	ATGACCTCCGCGGATCCTGCCGCCCCGGCGGGCCCCACGCTGGACACCGCCCACGGGTCGGTCGTCCTGCCCACCTTCCTGCCCGACGGCACCCGGGCCTCGGTCCGGGCGGTCGACACCCTCGACCTGTCGACGGTGGGGATCGAGGCGGTGATGGTCAACGCGATGCACCTGGCCCAGCGTCCCGGGTTGCAGACCATCAAGCGGGCCGGCGGACTCCACCGCTTCATGGCCTGGGACGGCGTGATCGTCTCCGACTCGGGCGGCTTCCAGGTCCTCTCCCTGCTCCGCAAGCAGGGCAAGAAGGGGTCGATCCGGGCCAGCGGGGTGACCTTCCAGGAGTCACCGAGCGCGAAGAAGATCGTGCTGACCCCGGAGAAGGTCATCGAGTGGCAGTTCGGGCTCCGCTCGGACGTGGTGGTCGCCCTCGACGACTGCACCGGCCCGGAGGACTCCCCGGCCGAGCAGATCGCCTCGACCGAGCGGACGATTCGATGGTTCCGGCAGGCCCGGCAGGCGTACGACCTCCAGTGCCGGCAGCGCCGGATGGACGAGCCGCCGCTGCTGGTCGGGGTGGTGCAGGGCGGCACCCGACCCCCGGAACTGCGTCAGCGCTGCGTCGACGCCCTCGTTGAGTCCGGCGCGCAGGGGTTCGGGTTCGGGGGCTGGCCGCTCAGCGCCGAGGGTGAGCTGGAGCGCGAGATGTTCGCTCTGCTCGCCCGGATCACCCCCCAGGACGCGCCGTTGTTCGCCCTGGGGGTCGGCCGGCCCGAGCACCTGGTCTCCCTCTGCGAGCTGGACATGCGTTGGGTCTTCGACTGCACGATCCCGACCCGGGACGCCCGGCACGGCCGGCTCTACGCGTTCGTGCCGGAGATCGCCGACCGGCTGCTCACCCCGGACCGGAGCTTCTACCAGAACGTCTACATCCTGGACGAGGAGAACTCCCGCAAGGACGAGCCGATCTGCGCGACCTGTGACTGCCCGACCTGCCGGCGGTACAGCCGCAGCTACCTGCACCACCTCTTCCGGGTGAAGGACGGTCTGGCGGACCGGCTCGCCACCCTGCACAACCTGCGCTTCTACACCCGGTTGCTGGAGATGATCCGGGCCGGGCGGATGGCCCAGCCGGGCCTGCGCGAGCCGGCCCGGCTCGGGTGA	MTSADPAAPAGPTLDTAHGSVVLPTFLPDGTRASVRAVDTLDLSTVGIEAVMVNAMHLAQRPGLQTIKRAGGLHRFMAWDGVIVSDSGGFQVLSLLRKQGKKGSIRASGVTFQESPSAKKIVLTPEKVIEWQFGLRSDVVVALDDCTGPEDSPAEQIASTERTIRWFRQARQAYDLQCRQRRMDEPPLLVGVVQGGTRPPELRQRCVDALVESGAQGFGFGGWPLSAEGELEREMFALLARITPQDAPLFALGVGRPEHLVSLCELDMRWVFDCTIPTRDARHGRLYAFVPEIADRLLTPDRSFYQNVYILDEENSRKDEPICATCDCPTCRRYSRSYLHHLFRVKDGLADRLATLHNLRFYTRLLEMIRAGRMAQPGLREPARLG	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	63.38	gnl|BL_ORD_ID|1764|hsp_num:0	1912			459	570	
BGC0000689.1|2-deoxystreptamine_21 # 20965 # 21192 # -1 # ID=1_21;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.776	BGC0000689.1|2-deoxystreptamine_21 	20965	21192	-	Loose	600	22.3274	tet(56)	33.33	3004603	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	CTCGACCCGATGCGGGAGCGCCGGGCCGGTTTCGCGGCCGAACGTGGCCTCGTCGACCAGCTGATCGCCGACGGCACCGAACGGACCCGGGAGGAGGTCCGGCGCACCCTGGCCGAGGTGCGTCGGGCGATGGGGCTGACCGGCGCGTACCAGCAGATCCGCCGCCGGGCCGAGCGGGCCCGGGGCAGGGCGGGCACGCCGGCCGCCGTGAGCACGAGCCGCGCCTGA	LDPMRERRAGFAAERGLVDQLIADGTERTREEVRRTLAEVRRAMGLTGAYQQIRRRAERARGRAGTPAAVSTSRA	MSKNIKILVIGAGVAGPAVCYWLRRFGFSPVLIEKYASIRKGGQALDVRGIATHIAREMGIYDQICEMRTRIERGRFVDSSGKVLHEEQGEKFGFRQDDEVEILRGDLVEILMKTIADVPCYFNQSIISIEQNADNVTVIFMDGRIEQYDLVIAADGIHSAIRRMIFEKNEYQLIHLGAYLSTFTIPNYLGLSHIDLECEANNKLVSINSDNNPEIARAGFMFRSQHLLNDIRDEQEQKQFLRDTFRDFGWETQNILNRMPESNDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLAFVGAYILAGELKVANGNYTRAFTRYNALLRSFVDANQKFGVWVSESFLVKDEVSKEIAEERSNKILAMIKSISNGITLPQYESS	19.28	gnl|BL_ORD_ID|792|hsp_num:0	3302			138	228	tetracycline; oxytetracycline
